Abstract
The emergence of multiple-drug-resistant strains of bacteria, the indiscriminate use of antibiotics and the increasing susceptibility of individuals with acquired immunodeficiency syndrome (AIDS) to infection from Mycobacterium induce an urgent need for development of new strategies to treat bacterial infections. Many natural products from marine sources are endowed with promising antibacterial activities, thus representing invaluable leads in the plans for antibiotic drug discovery. In this context, organic synthesis plays a decisive role in confirming (or revising) the chemical structures of the natural compounds allowing also access to suitable amounts of the target (and its analogs) for structureactivity relationship (SAR) investigations. In this overview, we focus on the total and partial synthesis of antibacterial marine metabolites and their related compounds published since 2000, discussing the retrosynthetic analysis of the strategies adopted. It includes the total synthesis of pestalone, squalamine, abyssomicin C and litosterol, the revised structure by total synthesis for the antituberculosis pseudopteroxazole and agelasine C, the preparation of the core-structure of zamamistatin and access to momeric and dimeric congeners of active peptide halocidin. Review with 132 references.
Keywords: Natural products, marine metabolites, drug discovery, synthesis, retrosynthetic analysis, antibiotic, antibacteria, antimycobacterial
Anti-Infective Agents in Medicinal Chemistry
Title: Recent Synthesis of Marine Natural Products with Antibacterial Activities
Volume: 6 Issue: 1
Author(s): Ines Mancini, Andrea Defant and Graziano Guella
Affiliation:
Keywords: Natural products, marine metabolites, drug discovery, synthesis, retrosynthetic analysis, antibiotic, antibacteria, antimycobacterial
Abstract: The emergence of multiple-drug-resistant strains of bacteria, the indiscriminate use of antibiotics and the increasing susceptibility of individuals with acquired immunodeficiency syndrome (AIDS) to infection from Mycobacterium induce an urgent need for development of new strategies to treat bacterial infections. Many natural products from marine sources are endowed with promising antibacterial activities, thus representing invaluable leads in the plans for antibiotic drug discovery. In this context, organic synthesis plays a decisive role in confirming (or revising) the chemical structures of the natural compounds allowing also access to suitable amounts of the target (and its analogs) for structureactivity relationship (SAR) investigations. In this overview, we focus on the total and partial synthesis of antibacterial marine metabolites and their related compounds published since 2000, discussing the retrosynthetic analysis of the strategies adopted. It includes the total synthesis of pestalone, squalamine, abyssomicin C and litosterol, the revised structure by total synthesis for the antituberculosis pseudopteroxazole and agelasine C, the preparation of the core-structure of zamamistatin and access to momeric and dimeric congeners of active peptide halocidin. Review with 132 references.
Export Options
About this article
Cite this article as:
Mancini Ines, Defant Andrea and Guella Graziano, Recent Synthesis of Marine Natural Products with Antibacterial Activities, Anti-Infective Agents in Medicinal Chemistry 2007; 6 (1) . https://dx.doi.org/10.2174/187152107779314151
DOI https://dx.doi.org/10.2174/187152107779314151 |
Print ISSN 1871-5214 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6018 |
Related Articles
-
Quinazolines as Apoptosis Inducers and Inhibitors: A Review of Patent Literature
Recent Patents on Anti-Cancer Drug Discovery Meet Our Editorial Board Member
Current Drug Delivery Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer
MicroRNA Thermostable Subunit Vaccines for Pulmonary Delivery: How Close Are We?
Current Pharmaceutical Design Nanobiotechnology: An Efficient Approach to Drug Delivery of Unstable Biomolecules
Current Protein & Peptide Science The Opposite Effect of L-kynurenine and Ahr Inhibitor Ch223191 on Apoptotic Protein Expression in Pancreatic Carcinoma Cells (Panc-1)
Anti-Cancer Agents in Medicinal Chemistry XMT-1001, A Novel Biodegradable Polyacetal Polymer Conjugate of Camptothecin in Clinical Development
Current Bioactive Compounds Editorial [ Hot Topic:Emerging Anticancer Effects of Antiresorptive Therapies (Guest Editor: Vera Hirsh)]
Anti-Cancer Agents in Medicinal Chemistry Calcium Antagonists: A Ready Prescription for Treating Infectious Diseases?
Current Topics in Medicinal Chemistry High Throughput Screening of Normal and Neoplastic Tissue Samples
Combinatorial Chemistry & High Throughput Screening Platelet Activity in the Pathophysiology of Inflammatory Bowel Diseases
Current Drug Targets Preparation and Characterization of Cisplatin-Incorporated Gelatin Nanocomplex for Cancer Treatment
Current Nanoscience Agents Targeting Ras Signaling Pathway
Current Pharmaceutical Design Mechanisms of Interferon Mediated Anti-Viral Resistance
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Pharmacogenomics of the Human ATP-Binding Cassette Transporter ABCG2
Current Pharmacogenomics Molecular Phenotyping of Mouse Mutant Resources by RNA Expression Profiling
Current Genomics Targeted Therapies for Advanced Non-Small Cell Lung Cancer
Combinatorial Chemistry & High Throughput Screening From Bortezomib to other Inhibitors of the Proteasome and Beyond
Current Pharmaceutical Design Chemokines as Pharmacological Targets
Mini-Reviews in Medicinal Chemistry Large Porous Hollow Particles: Lightweight Champions of Pulmonary Drug Delivery
Current Pharmaceutical Design